HLA ‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply
Open Access
- 14 November 2026
- journal article
- Published by Wiley in Transfusion
Abstract
Background: Low titer group O whole blood (LTOWB) use across the United States is increasing. This simulation calculated the number of female donors who would qualify for LTOWB donation if HLA‐antibody screening was implemented in different strategies. Methods: Using US nativity data and information on blood donors from 2023, a model was constructed that calculated how many of these donors would be males and nulliparous females, neither of which require HLA‐antibody screening before LTOWB donation. The model then calculated how many parous females would be HLA‐antibody sensitized based on each woman's parity in three antibody screening scenarios: all parous women, all parous women ≥50 years old, and all parous women older than the 99th percentile of the age of final birth. These calculations were performed for RhD‐negative and RhD‐positive donors. Results: The model calculated that there would be 222,239 RhD‐negative male and 74,655 nulliparous RhD‐negative female donors. If all group O RhD‐negative parous females were screened, 109,479 were calculated to not be HLA‐sensitized for a total of 406,373 LTOWB eligible donors. If only the group O RhD‐negative females ≥50 years were screened, 59,138 donors would not be HLA‐sensitized for a total of 356,032 LTOWB eligible donors. If only the group O RhD‐negative females ≥42 years, the 99th percentile for last birth age, were screened, 80,375 donors would not be HLA‐sensitized for a total of 377,269 LTOWB eligible donors. Higher numbers of LTOWB donors were realized when RhD‐positive males and females were modeled. Conclusion: HLA‐antibody screening realizes additional LTOWB donors.This publication has 9 references indexed in Scilit:
- Rate of Future Hemolytic Disease of the Fetus and Newborn Following the Prehospital Transfusion of RhD-Positive Blood Products to Females of Childbearing Potential in the United States of AmericaPrehospital Emergency Care, 2026
- ABO isoagglutinin titers in group “O” blood donorsAsian Journal of Transfusion Science, 2024
- Influence of donor age, sex and ethnicity on high‐titre anti‐A and ‐B: Review of 6 million donations from two national blood providersVox Sanguinis, 2024
- Emergency preparedness for mass casualty events: South Texas commentary on the development of a statewide emergency response systemTrauma Surgery & Acute Care Open, 2024
- Risk of future haemolytic disease of the fetus and newborn following the transfusion of Rh(D)‐positive blood products to Rh(D)‐negative childrenVox Sanguinis, 2021
- Identifying correlations between donor demographics and isohemagglutinin titers as a potential method to screen for low-titer group O whole bloodTransfusion and Apheresis Science, 2021
- The risk to future pregnancies of transfusing Rh(D)‐negative females of childbearing potential with Rh(D)‐positive red blood cells during trauma resuscitation is dependent on their age at transfusionVox Sanguinis, 2021
- It is time to reconsider the risks of transfusing RhD negative females of childbearing potential with RhD positive red blood cells in bleeding emergenciesTransfusion, 2019
- Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donorsTransfusion, 2010